Trade AstraZeneca ^AZN

Bridgefront Capital LLC Makes New $213,000 Investment in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca (AZN) Trial Reveals Promising Results for Bladder Cancer Treatment | AZN Stock News

IMFINZI® (durvalumab) regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial | Morningstar

Baird Financial Group Inc. Boosts Position in AstraZeneca PLC (NASDAQ:AZN)

US court shuts down AstraZeneca's challenge to Medicare drug price plan

AZN: Imfinzi Combination Improves Disease-Free Survival In Phase III High-Risk Bladder Cancer Trial

AstraZeneca breaks ground on new small molecule drug factory in Wuxi - Chinadaily.com.cn

AstraZeneca (AZN) Sees Increased Bullish Option Activity | AZN Stock News

AstraZeneca PLC (AZN) Shares Down 3.48% on May 8

Tempus AI Stock: Time to Double Down or Cut and Run? | Investing.com

AstraZeneca Loses Bid to Revive Drug Price Suit at Third Circuit

AstraZeneca cancer blockbuster Enhertu secures CDSCO nod for additional indication

Covenant Partners LLC Has $677,000 Position in AstraZeneca PLC (NASDAQ:AZN)

Aptus Capital Advisors LLC Grows Position in AstraZeneca PLC (NASDAQ:AZN)

Benjamin Edwards Inc. Has $3.67 Million Holdings in AstraZeneca PLC (NASDAQ:AZN)

Next-Generation Complement Therapeutics Market Set to Reach $12.9 Billion by 2034

Dual inhibition of DNA-PK and Polϴ boosts precision of diverse prime editing systems

Zanidatamab monotherapy or combined with chemotherapy in HER2-expressing gastroesophageal adenocarcinoma: a phase 1 trial

RANO criteria for response assessment of brain metastases based on amino acid PET imaging

Tempus AI, Inc. (NASDAQ:TEM) Q1 2025 Earnings Call Transcript

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2025 Earnings Call Transcript

AstraZeneca (AZN) Sees Positive Results in DESTINY-Breast11 Trial | AZN Stock News

Bank of America Corp DE Grows Stock Position in AstraZeneca PLC (NASDAQ:AZN)

Alteri Wealth LLC Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)

ENHERTU® Followed by THP Before Surgery Showed Statistically Sig

Tempus AI Inc (TEM) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...

Arcus Biosciences Inc (RCUS) Q1 2025 Earnings Call Highlights: Strategic Focus and Financial ...

Arcus Biosciences Q1 2025 Earnings: EPS Misses at -$1.14, Revenue Falls Short at $28 Million

AstraZeneca opens $300 million cell therapy manufacturing facility in Maryland | Fox Business

AstraZeneca (AZN): Impact of FDA's New Inspection Strategy on Foreign Facilities | AZN Stock News

AstraZeneca's (AZN) Calquence Gains EU Approval for Mantle Cell Lymphoma Treatment | AZN Stock News

Bamco Inc. NY Sells 25,592 Shares of AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca Canada and Plan International Canada Seek Next Generation of Sustainability Leaders for 2025-2026 Eureka Fellowship for Youth Changemakers in Canada

Bearing Point Capital LLC Purchases New Stake in AstraZeneca PLC (NASDAQ:AZN)

Axa S.A. Acquires 46,452 Shares of AstraZeneca PLC (NASDAQ:AZN)

Conformational landscapes of rigid and flexible molecules explored with variable temperature ion mobility-mass spectrometry

AZN: Upcoming Executive Order to Ease U.S. Drug Manufacturing Regulations | AZN Stock News

Astrazeneca's AZD-0022 solid preclinical results support further development | BioWorld

11,407 Shares in AstraZeneca PLC (NASDAQ:AZN) Purchased by Bearing Point Capital LLC

Mercer Global Advisors Inc. ADV Invests $10.49 Million in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Beacon Pointe Advisors LLC

AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Itau Unibanco Holding S.A.

AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of "Buy" from Analysts

Here's what top C-suites are saying about tariffs

Alembic Pharma's generic Ticagrelor tablets gets U.S. FDA nod - The Hindu

AstraZeneca (AZN) Achieves Major Milestones in Asthma Treatment Trials

Alembic receives FDA nod for AstraZeneca clotbuster generic

BREZTRI met primary endpoints in KALOS and LOGOS Phase III trials in asthma | AZN Stock News

AstraZeneca (AZN) Triple Therapy Shows Promise in Asthma Trials | AZN Stock News

AstraZeneca's New Asthma Treatment Shows Strong Results In Late-stage Trials

Clinical trial underway to assess effectiveness and safety of potential Long Covid treatment

Astrazeneca Pharma India Ltd Stock Price: Astrazeneca Phar Share Price Today | India Infoline

AI-enabled risk assessment for lung cancer reaches 5 million people around the world

Shore Capital Reiterates Buy Rating for AstraZeneca (LON:AZN)

AI by AstraZeneca spots lung cancer signs in 5 million people, enables early diagnosis - India Today

AstraZeneca's AI lung cancer screening program executes 5 mn tests, flags 50k individuals at high risk

AstraZeneca PLC (NASDAQ:AZN) Sees Large Decrease in Short Interest

AstraZeneca, Qure.ai complete AI-enabled assessment of 5 million chest X-rays for lung cancer

Lung Cancer Detection: AI-enabled risk assessment reaches 5 million people around the world

I think this could be the best investment opportunity on the FTSE 100

'Everything is possible': Pharmas navigate US market uncertainties | BioWorld

Zillions And Zillions: UCB Launches Myasthenia Gravis Campaign 05/01/2025

Kepler Capital Remains a Hold on AstraZeneca (AZN) | Markets Insider

AstraZeneca wins set-aside in Germany

AstraZeneca (AZN) Contemplates U.S. Production Expansion Amid Tariff Concerns | AZN Stock News

Guardian Capital LP Acquires 4,497 Shares of AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Kovitz Investment Group Partners LLC

AstraZeneca (LON:AZN) Receives "Buy" Rating from Shore Capital

AstraZeneca to scrap trails of Truqap in prostate cancer after interim analysis

AstraZeneca PLC (AZN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...

In the clinic for April 30, 2025 | BioWorld

Q1 2025 AstraZeneca PLC Earnings Call Transcript

PCSK9 Inhibitors Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | Sirnaomics, Vaxxinity, Verve Therapeutics, Xinlitai Biotechnology, Novo Nordisk, AstraZeneca, Akeso | ABNewswire

AstraZeneca (AZN) Q1 2025 Earnings Highlight 10% Revenue Growth

AstraZeneca to appeal invalidated diabetes patent in generics dispute

AstraZeneca moves some production to US amid tariff threat

AZN: EsoBiotec to Present Promising Data on ENaBL-T for CAR-T Therapies | AZN Stock News

AstraZeneca's (AZN) Calquence Combo Receives EU Approval Recommendation | AZN Stock News

AstraZeneca PLC (AZN) to Showcase Innovative In Vivo CAR-T Cell Therapy at ASGCT Annual Meeting ...

AstraZeneca says potential US tariffs manageable; faces another China fine | Company News - Business Standard

Drugmaker AstraZeneca shifts more production to US amid Trump tariffs | AstraZeneca | The Guardian

AstraZeneca (AZN) Confirms 2025 Sales Forecast Amid Potential U.S. Tariffs | AZN Stock News

AstraZeneca (AZN) Reports Q1 Revenue Below Expectations, Highlights Key Advancements | AZN ...

AstraZeneca 'firmly committed' to US amid tariff threat

AstraZeneca (AZN) Reports Mixed Q1 Results Amid Strong Growth Forecast | AZN Stock News

AstraZeneca Sales, Earnings Rise; Warns of Mounting Legal Challenges in China - 2nd Update | Morningstar

News Highlights: Top Company News of the Day - Tuesday at 5 AM ET | Morningstar

SOPHiA GENETICS Expands AstraZeneca Partnership to Advance Liquid Biopsy Worldwide

AstraZeneca Sales, Earnings Rise; Warns of Mounting Legal Challenges in China - Update | Morningstar

AstraZeneca has built resilient supply chains in U.S., China: CEO

AstraZeneca (AZN) Reports Strong Q1 Earnings and Reiterates Guidance

AstraZeneca's Q1 2025 Financial Results | AZN Stock News

FTSE 100 index near one-month lows as global sentiment sours

Moderna share price jumps as Oppenheimer upgrades stock

Week ahead: RBA poised to hike?

FTSE 100 Index: London stocks start week sharply lower

FTSE 100 Index: UK stocks edge higher ahead of CPI announcement

What Is Happening to the Bond Market: Bond Market Outlook 2025

Bond Market News Today: Alphabet (GOOGL) Back to Corporate Bond Market

Tariffs News Update: How Trump’s Policies Affect Bond Market?

Morning Note: Dollar Climbs on Trade Winds; BTC Soars; ECB's Dovish Tone

Stock Market Today: Dow Jones Up, Nvidia stock fluctuates, Nasdaq Rises

Morning Note: BoE Rate Cut?, US Jobs, Toyota Earnings Today

Trending forex pairs: EUR/USD Fluctuates, USD/TWD Drops, AUD/JPY Rises

Morning Note: Fed Rate Decision Awaited; Uber's Report Looms; Oil Recovers Ground